The exosomal surface CD63 in the CD63+ CAF-derived exosomes induces STAT3 activation in the recipient cells, which may be responsible for the different role of exosomal miR-22 in the induction of drug resistance in tumor cells compared to its intracellular source [112]. This evidence concerns the gene CD63 and neoplasm.